source
- HHS pauses enforcement of ban on compounding wellness peptides as FDA drafts new rulesHHS announced it will temporarily stop enforcing the existing prohibition on the compounding of certain peptides marketed for wellness. The agency said the move is intended to protect consumer saf…
- Biopharma leader urged to prioritize own job search after team layoffsA biopharma executive recently had to announce a downsizing of her team, and she described feeling guilt and grief for the impact on her direct reports. She said she would wait until every person…